{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:56:03Z","timestamp":1777949763862,"version":"3.51.4"},"reference-count":98,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"EDUFLUVAC","award":["602640"],"award-info":[{"award-number":["602640"]}]},{"name":"TRANSVAC2","award":["730964"],"award-info":[{"award-number":["730964"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["IF\/01704\/2014"],"award-info":[{"award-number":["IF\/01704\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/BBB-BIO\/1541\/2013"],"award-info":[{"award-number":["EXPL\/BBB-BIO\/1541\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["DFA\/BD\/8167\/2020"],"award-info":[{"award-number":["DFA\/BD\/8167\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04462\/2020"],"award-info":[{"award-number":["UIDB\/04462\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04462\/2020"],"award-info":[{"award-number":["UIDP\/04462\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>In the last decade, the interest in ferritin-based vaccines has been increasing due to their safety and immunogenicity. Candidates against a wide range of pathogens are now on Phase I clinical trials namely for influenza, Epstein-Barr, and SARS-CoV-2 viruses. Manufacturing challenges related to particle heterogeneity, improper folding of fused antigens, and antigen interference with intersubunit interactions still need to be overcome. In addition, protocols need to be standardized so that the production bioprocess becomes reproducible, allowing ferritin-based therapeutics to become readily available. In this review, the building blocks that enable the formulation of ferritin-based vaccines at an experimental stage, including design, production, and purification are presented. Novel bioengineering strategies of functionalizing ferritin nanoparticles based on modular assembly, allowing the challenges associated with genetic fusion to be circumvented, are discussed. Distinct up\/down-stream approaches to produce ferritin-based vaccines and their impact on production yield and vaccine efficacy are compared. Finally, ferritin nanoparticles currently used in vaccine development and clinical trials are summarized.<\/jats:p>","DOI":"10.3390\/pharmaceutics13101621","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T21:26:20Z","timestamp":1633728380000},"page":"1621","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Functionalizing Ferritin Nanoparticles for Vaccine Development"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6584-8331","authenticated-orcid":false,"given":"Margarida Q.","family":"Rodrigues","sequence":"first","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2781-901 Oeiras, Portugal"},{"name":"ITQB NOVA, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa, Av. da Rep\u00fablica, 2780-157 Oeiras, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1445-3556","authenticated-orcid":false,"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2781-901 Oeiras, Portugal"},{"name":"ITQB NOVA, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa, Av. da Rep\u00fablica, 2780-157 Oeiras, Portugal"}]},{"given":"Ant\u00f3nio","family":"Rold\u00e3o","sequence":"additional","affiliation":[{"name":"iBET, Instituto de Biologia Experimental e Tecnol\u00f3gica, Apartado 12, 2781-901 Oeiras, Portugal"},{"name":"ITQB NOVA, Instituto de Tecnologia Qu\u00edmica e Biol\u00f3gica Ant\u00f3nio Xavier, Universidade Nova de Lisboa, Av. da Rep\u00fablica, 2780-157 Oeiras, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.05.001","article-title":"Vaccine technologies: From whole organisms to rationally designed protein assemblies","volume":"120","author":"Karch","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.copbio.2017.03.018","article-title":"Bioengineering towards self-assembly of particulate vaccines","volume":"48","author":"Rehm","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/94.11.805","article-title":"Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?","volume":"94","author":"Parmiani","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1073\/pnas.1120611109","article-title":"Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis","volume":"109","author":"Yeste","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/nn405033r","article-title":"A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease","volume":"8","author":"Hunter","year":"2014","journal-title":"ACS Nano"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3488","article-title":"Applications of nanotechnology for immunology","volume":"13","author":"Smith","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/C9NR08958F","article-title":"Nanoparticle formulated vaccines: Opportunities and challenges","volume":"12","author":"Lung","year":"2020","journal-title":"Nanoscale"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2018","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.addr.2016.03.002","article-title":"Bioengineered protein-based nanocage for drug delivery","volume":"106","author":"Lee","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nmat3775","article-title":"Engineering synthetic vaccines using cues from natural immunity","volume":"12","author":"Irvine","year":"2013","journal-title":"Nat. Mater."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1152\/physrev.1978.58.2.317","article-title":"Ferritin: Structure, biosynthesis, and role in iron metabolism","volume":"58","author":"Munro","year":"1978","journal-title":"Physiol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1038\/am.2016.128","article-title":"Engineering protein nanocages as carriers for biomedical applications","volume":"9","author":"Bhaskar","year":"2017","journal-title":"NPG Asia Mater."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1021\/bi300752r","article-title":"Mechanisms of Mammalian Iron Homeostasis","volume":"51","author":"Pantopoulos","year":"2012","journal-title":"Biochemistry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/ind.2006.2.143","article-title":"Ferritin nanoparticle technology...A new platform for antigen presentation and vaccine development","volume":"2","author":"Li","year":"2006","journal-title":"Ind. Biotechnol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2018.02.042","article-title":"Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting","volume":"282","author":"Khoshnejad","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.bbagen.2009.12.005","article-title":"The ferritin superfamily: Supramolecular templates for materials synthesis","volume":"1800","author":"Uchida","year":"2010","journal-title":"Biochim. et Biophys. Acta (BBA) Gen. Subj."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.nbt.2014.12.006","article-title":"Ferritin family proteins and their use in bionanotechnology","volume":"32","author":"He","year":"2015","journal-title":"New Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1039\/C9BM00098D","article-title":"Ferritin nanocage-based antigen delivery nanoplatforms: Epitope engineering for peptide vaccine design","volume":"7","author":"Wang","year":"2019","journal-title":"Biomater. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chiou, B., and Connor, J.R. (2018). Emerging and Dynamic Biomedical Uses of Ferritin. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040124"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/B:BIOM.0000027692.24395.76","article-title":"Iron and proteins for iron storage and detoxification","volume":"17","author":"Chiancone","year":"2004","journal-title":"BioMetals"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.bi.56.070187.001445","article-title":"Ferritin: Structure, Gene Regulation, and Cellular Function in Animals, Plants, and Microorganisms","volume":"56","author":"Theil","year":"1987","journal-title":"Annu. Rev. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0005-2728(96)00022-9","article-title":"The ferritins: Molecular properties, iron storage function and cellular regulation","volume":"1275","author":"Harrison","year":"1996","journal-title":"Biochim. et Biophys. Acta (BBA) Bioenerg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.bbagen.2010.03.001","article-title":"Oxido-reduction is not the only mechanism allowing ions to traverse the ferritin protein shell","volume":"1800","author":"Watt","year":"2010","journal-title":"Biochim. et Biophys. Acta (BBA) Gen. Subj."},{"key":"ref_26","unstructured":"Byska, J., Krone, M., and Sommer, B. (2018). Mol*: Towards a Common Library and Tools for Web Molecular Graphics. Workshop on Molecular Graphics and Visual Analysis of Molecular Data, The Eurographics Association."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"W431","DOI":"10.1093\/nar\/gkab314","article-title":"Mol* Viewer: Modern web app for 3D visualization and analysis of large biomolecular structures","volume":"49","author":"Sehnal","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/271282a0","article-title":"Electron density map of apoferritin at 2.8-\u00c5 resolution","volume":"271","author":"Banyard","year":"1978","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00257503","article-title":"Mechanism of the self-assembly of apoferritin from horse spleen","volume":"15","author":"Gerl","year":"1987","journal-title":"Eur. Biophys. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acs.biochem.5b01152","article-title":"Ferritin Assembly Revisited: A Time-Resolved Small-Angle X-ray Scattering Study","volume":"55","author":"Sato","year":"2016","journal-title":"Biochemistry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/bj2200717","article-title":"Iron-induced changes in rat liver isoferritins","volume":"220","author":"Treffry","year":"1984","journal-title":"Biochem. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0021-9258(17)43653-2","article-title":"Cell-specific properties of red cell and liver ferritin from bullfrog tadpoles probed by phosphorylation in vitro","volume":"259","author":"Ihara","year":"1984","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bj1990565","article-title":"Detection of a glycosylated subunit in human serum ferritin","volume":"199","author":"Cragg","year":"1981","journal-title":"Biochem. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/cs0580259","article-title":"Sialic Acid and the Microheterogeneity of Human Serum Ferritin","volume":"58","author":"Cragg","year":"1980","journal-title":"Clin. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2141.1979.tb01166.x","article-title":"The Kinetics of Serum and Tissue Ferritins: Relation to Carbohydrate Content","volume":"42","author":"Halliday","year":"1979","journal-title":"Br. J. Haematol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3389\/fimmu.2018.01093","article-title":"Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/2211-5463.12267","article-title":"Structure-based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeae","volume":"7","author":"Wang","year":"2017","journal-title":"FEBS Open Bio"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12951-019-0446-6","article-title":"A milk-based self-assemble rotavirus VP6\u2013ferritin nanoparticle vaccine elicited protection against the viral infection","volume":"17","author":"Li","year":"2019","journal-title":"J. Nanobiotechnology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virol.2020.10.007","article-title":"Immunization with a recombinant fusion of porcine reproductive and respiratory syndrome virus modified GP5 and ferritin elicits enhanced protective immunity in pigs","volume":"552","author":"Ma","year":"2020","journal-title":"Virology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10529-019-02755-6","article-title":"Expression, purification, and characterisation of recombinant ferritin in insect cells using the baculovirus expression system","volume":"42","author":"Qu","year":"2019","journal-title":"Biotechnol. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1016\/j.vaccine.2020.06.063","article-title":"A ferritin nanoparticle vaccine for foot-and-mouth disease virus elicited partial protection in mice","volume":"38","author":"Chen","year":"2020","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhao, Z., Chen, X., Chen, Y., Li, H., Fang, K., Chen, H., Li, X., and Qian, P. (2021). A Self-Assembling Ferritin Nanoplatform for Designing Classical Swine Fever Vaccine: Elicitation of Potent Neutralizing Antibody. Vaccines, 9.","DOI":"10.3390\/vaccines9010045"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kelly, H.G., Tan, H.X., Juno, J.A., Esterbauer, R., Ju, Y., Jiang, W., Wimmer, V.C., Duckworth, B.C., Groom, J.R., and Caruso, F. (2020). Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation. JCI Insight, 5.","DOI":"10.1172\/jci.insight.136653"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kim, Y.-I., Kim, D., Yu, K.-M., Seo, H.D., Lee, S.-A., Casel, M.A.B., Jang, S.-G., Kim, S., Jung, W., and Lai, C.-J. (2021). Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets. mBio, 12.","DOI":"10.1128\/mBio.00230-21"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-0183-8","article-title":"Design of a broadly reactive Lyme disease vaccine","volume":"5","author":"Kamp","year":"2020","journal-title":"npj Vaccines"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Darricarr\u00e8re, N., Pougatcheva, S., Duan, X., Rudicell, R.S., Chou, T.-H., DiNapoli, J., Ross, T.M., Alefantis, T., Vogel, T.U., and Kleanthous, H. (2018). Development of a Pan-H1 Influenza Vaccine. J. Virol., 92.","DOI":"10.1128\/JVI.01349-18"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"eaba6466","DOI":"10.1126\/sciimmunol.aba6466","article-title":"A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain","volume":"5","author":"Swanson","year":"2020","journal-title":"Sci. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbagen.2016.10.007","article-title":"Probing bulky ligand entry in engineered archaeal ferritins","volume":"1861","author":"Calisti","year":"2017","journal-title":"Biochim. et Biophys. Acta (BBA) Gen. Subj."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41423-021-00643-6","article-title":"Ferritin nanoparticle-based SARS-CoV-2 RBD vaccine induces a persistent antibody response and long-term memory in mice","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1016\/j.biomaterials.2012.03.055","article-title":"Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform","volume":"33","author":"Kang","year":"2012","journal-title":"Biomaterials"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.nano.2013.11.003","article-title":"Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development","volume":"10","author":"Han","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11344","DOI":"10.1038\/s41598-017-10297-y","article-title":"Programmed Self-Assembly of a Biochemical and Magnetic Scaffold to Trigger and Manipulate Microtubule Structures","volume":"7","author":"Ducasse","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nano.2018.11.009","article-title":"Ferritin nanoparticle-based SpyTag\/SpyCatcher-enabled click vaccine for tumor immunotherapy","volume":"16","author":"Wang","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"ref_61","first-page":"647","article-title":"Humanized archaeal ferritin as a tool for cell targeted delivery","volume":"9","author":"Trabuco","year":"2016","journal-title":"Nanoscale"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"105451","DOI":"10.1016\/j.pep.2019.105451","article-title":"Application of crossflow ultrafiltration for scaling up the purification of a recombinant ferritin","volume":"163","author":"Palombarini","year":"2019","journal-title":"Protein Expr. Purif."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1021\/acsinfecdis.7b00192","article-title":"Two-Component Ferritin Nanoparticles for Multimerization of Diverse Trimeric Antigens","volume":"4","author":"Georgiev","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/nl104141g","article-title":"Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal Imaging","volume":"11","author":"Lin","year":"2011","journal-title":"Nano Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1021\/acs.bioconjchem.8b00004","article-title":"Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and Imaging","volume":"29","author":"Khoshnejad","year":"2018","journal-title":"Bioconjugate Chem."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Yao, D., Lao, F., Zhang, Z., Liu, Y., Cheng, J., Ding, F., Wang, X., Xi, L., Wang, C., and Yan, X. (2020). Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2. bioRxiv, 115618.","DOI":"10.1101\/2020.05.25.115618"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pep.2015.11.018","article-title":"Expression, purification, and characterization of recombinant human L-chain ferritin","volume":"119","author":"Zou","year":"2016","journal-title":"Protein Expr. Purif."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16626","DOI":"10.1021\/ja0655690","article-title":"Targeting of Cancer Cells with Ferrimagnetic Ferritin Cage Nanoparticles","volume":"128","author":"Uchida","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2147\/IJN.S28242","article-title":"Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles","volume":"7","author":"Ceci","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1166\/jbn.2015.1946","article-title":"In Vivo Targeting of Cutaneous Melanoma Using an Melanoma Stimulating Hormone-Engineered Human Protein Cage with Fluorophore and Magnetic Resonance Imaging Tracers","volume":"11","author":"Vannucci","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"35182","DOI":"10.1038\/srep35182","article-title":"Engineered Human Ferritin Nanoparticles for Direct Delivery of Tumor Antigens to Lymph Node and Cancer Immunotherapy","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e1703207","DOI":"10.1002\/smll.201703207","article-title":"Intranasal Nanovaccine Confers Homo- and Hetero-Subtypic Influenza Protection","volume":"14","author":"Qi","year":"2018","journal-title":"Small"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7442","DOI":"10.1002\/chem.202000075","article-title":"Nanobody-Ferritin Conjugate for Targeted Photodynamic Therapy","volume":"26","author":"Liu","year":"2020","journal-title":"Chem. A Eur. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/sj.emboj.7601087","article-title":"Definition of the bacterial N-glycosylation site consensus sequence","volume":"25","author":"Kowarik","year":"2006","journal-title":"EMBO J."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0307-4412(86)90203-7","article-title":"The structure and function of ferritin","volume":"14","author":"Harrison","year":"1986","journal-title":"Biochem. Educ."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nchembio.1163","article-title":"Re-engineering protein interfaces yields copper-inducible ferritin cage assembly","volume":"9","author":"Kane","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1039\/C6CC03108K","article-title":"Engineering protein interfaces yields ferritin disassembly and reassembly under benign experimental conditions","volume":"52","author":"Chen","year":"2016","journal-title":"Chem. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-015-0210-4","article-title":"Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity","volume":"12","author":"Sliepen","year":"2015","journal-title":"Retrovirology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1038\/ncomms12041","article-title":"Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles","volume":"7","author":"He","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"American Association for the Advancement of Science (2020). An Erratum for the Research Article: \u201cHIV-1 vaccine design through minimizing envelope metastability\u201d by L. He, S. Kumar, J. D. Allen, D. Huang, X. Lin, C. J. Mann, K. L. Saye-Francisco, J. Copps, A. Sarkar, S. S. Blizard, G. Ozorowski, D. Sok, M. Crispin, A. B. Ward, D. Nemazee, D. R. Burton, I. A. Wilson and J. Zhu. Sci. Adv., 6, eabd8600.","DOI":"10.1126\/sciadv.abd8600"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/acscentsci.0c01405","article-title":"A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice","volume":"7","author":"Powell","year":"2021","journal-title":"ACS Central Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"eabf1591","DOI":"10.1126\/sciadv.abf1591","article-title":"Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates","volume":"7","author":"He","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Joyce, M.G., Chen, W.-H., Sankhala, R.S., Hajduczki, A., Thomas, P.V., Choe, M., Chang, W., Peterson, C.E., Martinez, E., and Morrison, E.B. (2021). SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. bioRxiv Prepr. Serv. Biol., 150.","DOI":"10.1093\/ofid\/ofab466.762"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"eaaz6225","DOI":"10.1126\/sciadv.aaz6225","article-title":"Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines","volume":"6","author":"He","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"12278","DOI":"10.1039\/c3nr04268e","article-title":"Antibody\u2013drug conjugates: Targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin","volume":"5","author":"Falvo","year":"2013","journal-title":"Nanoscale"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-019-4603-5","article-title":"Construction and in vitro studies of magnetic-apoferritin nanocages conjugated with KGDS peptide targeted at activated platelets for the MRI diagnosis of thrombus","volume":"21","author":"Luo","year":"2019","journal-title":"J. Nanoparticle Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00424-012-1208-6","article-title":"Manipulating signaling at will: Chemically-inducible dimerization (CID) techniques resolve problems in cell biology","volume":"465","author":"Derose","year":"2013","journal-title":"Pfl\u00fcgers Arch. Eur. J. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1021\/acscentsci.0c00940","article-title":"Site-Specific Bioconjugation through Enzyme-Catalyzed Tyrosine\u2013Cysteine Bond Formation","volume":"6","author":"Lobba","year":"2020","journal-title":"ACS Central Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1021\/acs.bioconjchem.0c00308","article-title":"An Apoferritin\u2013Hemagglutinin Conjugate Vaccine with Encapsulated Nucleoprotein Antigen Peptide from Influenza Virus Confers Enhanced Cross Protection","volume":"31","author":"Wei","year":"2020","journal-title":"Bioconjugate Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.pnsc.2008.12.007","article-title":"Design and optimization of a linker for fusion protein construction","volume":"19","author":"Zhang","year":"2009","journal-title":"Prog. Nat. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/protein\/14.9.711","article-title":"Stable linker peptides for a cellulose-binding domain\u2013lipase fusion protein expressed in Pichia pastoris","volume":"14","author":"Gustavsson","year":"2001","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1021\/acs.biochem.7b00902","article-title":"Tuning the Flexibility of Glycine-Serine Linkers To Allow Rational Design of Multidomain Proteins","volume":"56","author":"Krom","year":"2017","journal-title":"Biochemistry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","article-title":"Fusion protein linkers: Property, design and functionality","volume":"65","author":"Chen","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1002\/jps.23733","article-title":"O-xylosylation in a Recombinant Protein is Directed at a Common Motif on Glycine\u2013Serine Linkers","volume":"102","author":"Spencer","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1021\/jp410788r","article-title":"Effects of Branched O-Glycosylation on a Semiflexible Peptide Linker","volume":"118","author":"Johnson","year":"2014","journal-title":"J. Phys. Chem. B"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2019.09.002","article-title":"Ferritin drug carrier (FDC) for tumor targeting therapy","volume":"311-312","author":"He","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1021\/acs.bioconjchem.7b00253","article-title":"Development and Application of Synthetic Affinity Ligands for the Purification of Ferritin-Based Influenza Antigens","volume":"28","author":"Jacob","year":"2017","journal-title":"Bioconjugate Chem."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/10\/1621\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:09:42Z","timestamp":1760166582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/10\/1621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":98,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["pharmaceutics13101621"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13101621","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]}}}